PRESS RELEASE published on 09/02/2025 at 13:00, 9 months 18 days ago Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism Moderna, Inc. to present abstracts on mRNA therapeutics at the 2025 ICIEM including PA, MMA, and GSD1a programs in Kyoto, Japan. Company's first time presenting data for MMA and GSD1a Moderna Inc. MRNA Therapeutics ICIEM Abstracts Kyoto Japan
BRIEF published on 08/27/2025 at 19:29, 9 months 24 days ago Les vaccins Moderna contre la COVID-19 mis à jour approuvés par la FDA américaine Approbation De La FDA Moderne Vaccin Contre Le Covid-19 Variante Du SRAS-CoV-2 Spikevax Et MNEXSPIKE
BRIEF published on 08/27/2025 at 19:29, 9 months 24 days ago Moderna's Updated COVID-19 Vaccines Approved by U.S. FDA FDA Approval COVID-19 Vaccine Moderna SARS-CoV-2 Variant Spikevax And MNEXSPIKE
PRESS RELEASE published on 08/27/2025 at 19:24, 9 months 24 days ago Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 Moderna announces FDA approval for updated Spikevax® and mNEXSPIKE® COVID-19 vaccines targeting LP.8.1 variant to prevent severe outcomes. Vaccines available soon FDA Approval Moderna COVID-19 Vaccines Spikevax MNEXSPIKE
BRIEF published on 08/22/2025 at 15:30, 9 months 29 days ago Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine COVID-19 Vaccine Moderna Health Canada Approval Canadian Manufacturing Biomanufacturing Leadership
BRIEF published on 08/22/2025 at 15:30, 9 months 29 days ago Moderna reçoit l'approbation de Santé Canada pour son vaccin contre la COVID-19 mis à jour Moderne Vaccin Contre Le Covid-19 Fabrication Canadienne Approbation De Santé Canada Leadership En Bioproduction
PRESS RELEASE published on 08/22/2025 at 15:25, 9 months 29 days ago Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 Moderna's Spikevax COVID-19 vaccine for SARS-CoV-2 LP.8.1 variant authorized in Canada, with all 2025 doses produced domestically. Leadership in biomanufacturing highlighted COVID-19 Vaccine Canada Moderna Spikevax Biomanufacturing
BRIEF published on 08/21/2025 at 13:05, 9 months 30 days ago Moderna participera aux principales conférences de septembre 2025 Conférences D'investisseurs Moderne Webcast En Direct Médecine À Base D'ARNm Présentation Des Soins De Santé
BRIEF published on 08/21/2025 at 13:05, 9 months 30 days ago Moderna to Participate in Major September 2025 Conferences Investor Conferences MRNA Medicine Moderna Live Webcast Healthcare Presentation
PRESS RELEASE published on 08/21/2025 at 13:00, 9 months 30 days ago Moderna to Present at Upcoming Conferences in September 2025 Moderna, Inc. to participate in upcoming investor conferences. The company's innovative mRNA technology redefines medicine creation, focusing on infectious diseases, oncology, and more Investor Conferences Healthcare COVID-19 Vaccine MRNA Technology Moderna
Published on 06/20/2026 at 01:00, 1 day 3 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 4 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 3 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 3 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 7 hours 17 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 22 hours 42 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 8 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 8 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 9 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 9 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 9 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 9 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 9 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
